CpG oligonucleotides as immunotherapeutic adjuvants: innovative applications and delivery strategies

Advanced Drug Delivery Reviews

Volumn 61, Issue 3, 2009, Pages 193-194

  Salem, Aliasger K ^a   Weiner, George J ^b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; CPG OLIGODEOXYNUCLEOTIDE; IMMUNOLOGICAL ADJUVANT; TOLL LIKE RECEPTOR 9; TOLL LIKE RECEPTOR AGONIST;

CANCER IMMUNOTHERAPY; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DRUG DELIVERY SYSTEM; DRUG RESEARCH; EDITORIAL; IMMUNOMODULATION; IMMUNOTHERAPY; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CPG ISLANDS; DRUG DELIVERY SYSTEMS; HUMANS; OLIGODEOXYRIBONUCLEOTIDES;

EID: 61849086814     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2008.12.003     Document Type: Editorial

References (30)

1. Krieg A.M., Yi A.K., Matson S., Waldschmidt T.J., Bishop G.A., Teasdale R., Koretzky G.A., and Klinman D.M. CpG motifs in bacterial-DNA trigger direct B-cell activation. Nature 374 6522 (1995) 546-549
2. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., Matsumoto M., Hoshino K., Wagner H., Takeda K., and Akira S. A Toll-like receptor recognizes bacterial DNA. Nature 408 6813 (2000) 740-745
3. Akira S., Takeda K., and Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nature Immunology 2 8 (2001) 675-680
4. Millan C.L.B., Weeratna R., Krieg A.M., Siegrist C.A., and Davis H.L. CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice. Proceedings of the National Academy of Sciences of the United States of America 95 26 (1998) 15553-15558
5. Roman M., MartinOrozco E., Goodman S., Nguyen M.D., Sato Y., Ronaghy A., Kornbluth R.S., Richman D.D., Carson D.A., and Raz E. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nature Medicine 3 8 (1997) 849-854
6. Stacey K.J., Sweet M.J., and Hume D.A. Macrophages ingest and are activated by bacterial DNA. Journal of Immunology 157 5 (1996) 2116-2122
7. Sun S.Q., Zhang X.H., Tough D.F., and Sprent J. Type I interferon-mediated stimulation of T cells by CgG DNA. Journal of Experimental Medicine 188 12 (1998) 2335-2342
8. Cowdery J.S., Krieg A.M., Hooker N.A., Mildenstein K.L., and Chace J.H. Bacterial DNA-induced NK cell IFN-gamma production is dependent on macrophage secretion of IL-12. Journal of Allergy and Clinical Immunology 99 1 (1997) 1970-1970
9. Halpern M.D., Kurlander R.J., and Pisetsky D.S. Bacterial DNA induces murine interferon-gamma production by stimulation of interleukin-12 and tumor necrosis factor-alpha. Cellular Immunology 167 1 (1996) 72-78
10. Yi A.K., Chace J.H., Cowdery J.S., and Krieg A.M. IFN-gamma promotes IL-6 and IgM secretion in response to CpG motifs in bacterial DNA and oligodeoxynucleotides. Journal of Immunology 156 2 (1996) 558-564
11. Hartmann G., Weiner G.J., and Krieg A.M. CpG DNA: A potent signal for growth, activation, and maturation of human dendritic cells. Proceedings of the National Academy of Sciences of the United States of America 96 16 (1999) 9305-9310
12. Krieg A.M. CpG motifs: the active ingredient in bacterial extracts?. Nature Medicine 9 7 (2003) 831-835
13. Vollmer J., Weeratna R., Payette P., Jurk M., Schetter C., Laucht M., Wader T., Tluk S., Liu M., Davis H.L., and Krieg A.M. Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities. European Journal of Immunology 34 1 (2004) 251-262
14. Zhang X.Q., Dahle C.E., Baman N.K., Rich N., Weiner G.J., and Salem A.K. Potent antigen-specific immune responses stimulated by codelivery of CpG ODN and antigens in degradable microparticles. Journal of Immunotherapy 30 5 (2007) 469-478
15. Zhang X.Q., Dahle C.E., Weiner G.J., and Salem A.K. A comparative study of the antigen-specific immune response induced by co-delivery of CpG ODN and antigen using fusion molecules or biodegradable microparticles. Journal of Pharmaceutical Sciences 96 (2007) 3283-3292
16. Zaks K., Jordan M., Guth A., Sellins K., Kedl R., Izzo A., Bosio C., and Dow S. Efficient immunization and cross-priming by vaccine adjuvants containing TLR3 or TLR9 agonists complexed to cationic liposomes. Journal of Immunology 176 12 (2006) 7335-7345
17. Salem A.K., Hung C.F., Kim T.W., Wu T.C., Searson P.C., and Leong K.W. Multi-component nanorods for vaccination applications. Nanotechnology 16 4 (2005) 484-487
18. Intra J., Glasgow J.M., Mai H.Q., and Salem A.K. Pulsatile release of biomolecules from polydimethylsiloxane (PDMS) chips with hydrolytically degradable seals. Journal of Controlled Release 127 (2008) 280-287
19. Krishnamachari Y., Pearce M.E., and Salem A.K. Self-assembly of cell-microparticle hybrids. Advanced Materials 20 5 (2008) 989-993
20. Singh M., Briones M., Ott G., and O'Hagan D. Cationic microparticles: a potent delivery system for DNA vaccines. Proceedings of the National Academy of Sciences of the United States of America 97 2 (2000) 811-816
21. Xie H., Gursel I., Ivins B.E., Singh M., O'Hagan D.T., Ulmer J.B., and Klinman D.M. CpG oligodeoxynucleotides adsorbed onto polylactide-co-glycolide microparticles improve the immunogenicity and protective activity of the licensed anthrax vaccine. Infection and Immunity 73 2 (2005) 828-833
22. de Jong S., Chikh G., Sekirov L., Raney S., Semple S., Klimuk S., Yuan N., Hope M., Cullis P., and Tam Y. Encapsulation in liposomal nanoparticles enhances the immunostimulatory, adjuvant and anti-tumor activity of subcutaneously administered CpG ODN. Cancer Immunology Immunotherapy 56 8 (2007) 1251-1264
23. Mutwiri G., Benjamin P., Soita H., and Babiuk L.A. Co-administration of polyphosphazenes with CpG oligodeoxynucleotides strongly enhances immune responses in mice immunized with Hepatitis B virus surface antigen. Vaccine 26 22 (2008) 2680-2688
24. Heit A., Schmitz F., O'Keeffe M., Staib C., Busch D.H., Wagner H., and Huster K.M. Protective CD8 T cell immunity triggered by CpG-protein conjugates competes with the efficacy of live vaccines. Journal of Immunology 174 7 (2005) 4373-4380
25. Klinman D.M., Yi A.K., Beaucage S.L., Conover J., and Krieg A.M. CpG motifs present in bacterial DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma. Proceedings of the National Academy of Sciences of the United States of America 93 7 (1996) 2879-2883
26. Kitagaki K., Businga T.R., and Kline J.N. Oral administration of CpG-ODNs suppresses antigen-induced asthma in mice. Clinical and Experimental Immunology 143 2 (2006) 249-259
27. Kline J.N., Waldschmidt T.J., Businga T.R., Lemish J.E., Weinstock J.V., Thorne P.S., and Krieg A.M. Cutting edge: modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma. Journal of Immunology 160 6 (1998) 2555-2559
28. Weiner G.J., Liu H.M., Wooldridge J.E., Dahle C.E., and Krieg A.M. Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization. Proceedings of the National Academy of Sciences of the United States of America 94 20 (1997) 10833-10837
29. Lubaroff D.M., Karan D., Andrews M.P., Acosta A., Abouassaly C., Sharma M., and Krieg A.M. Decreased cytotoxic T cell activity generated by co-administration of PSA vaccine and CpG ODN is associated with increased tumor protection in a mouse model of prostate cancer. Vaccine 24 35-36 (2006) 6155-6162
30. Sandler A.D., Chihara H., Kobayashi G., Zhu X.Y., Miller M.A., Scott D.L., and Krieg A.M. CpG oligonucleotides enhance the tumor antigen-specific immune response of a granulocyte macrophage colony-stimulating factor-based vaccine strategy in neuroblastoma. Cancer Research 63 2 (2003) 394-399